BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 741967)

  • 21. Fibrinolysis and thrombosis in Behçet's disease.
    Sobel JD; Tabori S; Tatarski I
    Dermatologica; 1974; 148(2):93-7. PubMed ID: 4837654
    [No Abstract]   [Full Text] [Related]  

  • 22. Behçet's disease and thrombophilia.
    Leiba M; Sidi Y; Gur H; Leiba A; Ehrenfeld M
    Ann Rheum Dis; 2001 Dec; 60(12):1081-5. PubMed ID: 11709446
    [No Abstract]   [Full Text] [Related]  

  • 23. Thrombophilic factors are not the leading cause of thrombosis in Behçet's disease.
    Leiba M; Seligsohn U; Sidi Y; Harats D; Sela BA; Griffin JH; Livneh A; Rosenberg N; Gelernter I; Gur H; Ehrenfeld M
    Ann Rheum Dis; 2004 Nov; 63(11):1445-9. PubMed ID: 15479893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activated protein C levels in Behçet's disease and risk of venous thrombosis.
    Navarro S; Ricart JM; Medina P; Vayá A; Villa P; Todolí J; Estellés A; Micó ML; Aznar J; España F
    Br J Haematol; 2004 Aug; 126(4):550-6. PubMed ID: 15287949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Studies on fibrinolytic activity in Behçet's disease. II. Fibrin degradation product].
    Saito K
    Nippon Ganka Gakkai Zasshi; 1973 Jul; 77(7):693-8. PubMed ID: 4738794
    [No Abstract]   [Full Text] [Related]  

  • 26. [Behçet's disease and lupus anticoagulant].
    Torrelo Fernández A; España Alonso A; Medina Montalvo S; Ledo Pozueta A
    Rev Clin Esp; 1990; 187(3):153. PubMed ID: 2126636
    [No Abstract]   [Full Text] [Related]  

  • 27. [Intracardiac thrombosis: unusual complication of Behcet's disease].
    Fekih M; Fennira S; Ghodbane L; Zaouali RM
    Tunis Med; 2004 Aug; 82(8):785-90. PubMed ID: 15532777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemostatic parameters in Behçet's disease: a reappraisal.
    Koşar A; Oztürk M; Haznedaroğlu IC; Karaaslan Y
    Rheumatol Int; 2002 May; 22(1):9-15. PubMed ID: 12120913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abnormalities of T-cell subsets in Behçet's syndrome.
    Lim SD; Haw CR; Kim NI; Fusaro RM
    Arch Dermatol; 1983 Apr; 119(4):307-10. PubMed ID: 6220679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Behçet's disease: a vascular function study by the venostasis test and DDAVP infusion].
    Le Roux G; Guillevin L; Casassus P; Gayraud M; Limon S
    Rev Med Interne; 1985 Mar; 6(2):111-5. PubMed ID: 3923585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Studies on blood coagulability activity in Behçet's disease (author's transl)].
    Saito K; Higuchi M; Sugiura S
    Nippon Ganka Gakkai Zasshi; 1976 Jan; 80(1):1-6. PubMed ID: 943906
    [No Abstract]   [Full Text] [Related]  

  • 32. Pathological haemostasis and "prothrombotic state" in Behçet's disease.
    Kiraz S; Ertenli I; Oztürk MA; Haznedaroğlu IC; Celik I; Calgüneri M
    Thromb Res; 2002 Jan; 105(2):125-33. PubMed ID: 11958802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated FVIII and FIX level in a Behçet's disease patient with intracardiac thrombosis and pulmonary arterial aneurysms.
    Atalay F; Ernam D; Okten F; Akar N
    Thromb Res; 2005; 115(1-2):159-61. PubMed ID: 15567468
    [No Abstract]   [Full Text] [Related]  

  • 34. [Fibrinolytic activity in Behçet's disease].
    Kogure M; Motoji K
    Nippon Ganka Gakkai Zasshi; 1972 Mar; 76(3):114-21. PubMed ID: 4261805
    [No Abstract]   [Full Text] [Related]  

  • 35. Von Willebrand factor in Behçet's syndrome.
    Yazici H; Hekim N; Ozbakir F; Yurdakul S; Tüzün Y; Pazarli H; Müftüoğlu A
    J Rheumatol; 1987 Apr; 14(2):305-6. PubMed ID: 3496454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum interleukin 18 and tumour necrosis factor-alpha levels are increased in Behcet's disease.
    Oztas MO; Onder M; Gurer MA; Bukan N; Sancak B
    Clin Exp Dermatol; 2005 Jan; 30(1):61-3. PubMed ID: 15663506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Haemostasis, thrombosis, and endothelium in Behçet's disease.
    Haznedaroğlu IC; Celik I; Büyükaşik Y; Koşar A; Kirazli S; Dündar SV
    Acta Haematol; 1998; 99(4):236-7. PubMed ID: 9644305
    [No Abstract]   [Full Text] [Related]  

  • 38. Circulated activated platelets and increased platelet reactivity in patients with Behçet's disease.
    Akar S; Ozcan MA; Ateş H; Gürler O; Alacacioglu I; Ozsan GH; Akkoç N; Ozkan S; Demirkan F; Onen F
    Clin Appl Thromb Hemost; 2006 Oct; 12(4):451-7. PubMed ID: 17000890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of leptin level and Ob gene polymorphism in patients with Behcet's disease.
    Okudan N; Acar H; Gökbel H; Mevlitoğlu I; Sari F
    Arch Dermatol Res; 2006 Aug; 298(3):127-30. PubMed ID: 16786343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Behçet's syndrome presenting as myocardial infarction with impaired blood fibrinolysis.
    Hutchison SJ; Belch JJ
    Br Heart J; 1984 Dec; 52(6):686-7. PubMed ID: 6508969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.